Projects per year
Personal profile
Research interests
- COVID-19
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Chien-Te Tseng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Pilot lethality study of hACE2 transgenic mice against SARS-CoV-2 infection
1/15/21 → 6/30/22
Project: Other project
-
Bepridil as a COVID-19 Therapeutics: A Rapid, Low-Cost Solution to the Current Pandemic
1/1/21 → 7/14/22
Project: Other project
-
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells
Mellott, D. M., Tseng, C. T., Drelich, A., Fajtová, P., Chenna, B. C., Kostomiris, D. H., Hsu, J., Zhu, J., Taylor, Z. W., Kocurek, K. I., Tat, V., Katzfuss, A., Li, L., Giardini, M. A., Skinner, D., Hirata, K., Yoon, M. C., Beck, S., Carlin, A. F., Clark, A. E. & 11 others, , Apr 16 2021, In: ACS Chemical Biology. 16, 4, p. 642-650 9 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors**
Yang, K. S., Ma, X. R., Ma, Y., Alugubelli, Y. R., Scott, D. A., Vatansever, E. C., Drelich, A. K., Sankaran, B., Geng, Z. Z., Blankenship, L. R., Ward, H. E., Sheng, Y. J., Hsu, J. C., Kratch, K. C., Zhao, B., Hayatshahi, H. S., Liu, J., Li, P., Fierke, C. A., Tseng, C. T. K. & 2 others, , Mar 18 2021, In: ChemMedChem. 16, 6, p. 942-948 7 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering
Zhu, J., Ananthaswamy, N., Jain, S., Batra, H., Tang, W. C., Lewry, D. A., Richards, M. L., David, S. A., Kilgore, P. B., Sha, J., Drelich, A., Tseng, C. T. K., Chopra, A. K. & Rao, V. B., Sep 2021, In: Science Advances. 7, 37, eabh1547.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 (Nature Communications, (2020), 11, 1, (5214), 10.1038/s41467-020-19055-7)
Xie, X., Muruato, A. E., Zhang, X., Lokugamage, K. G., Fontes-Garfias, C. R., Zou, J., Liu, J., Ren, P., Balakrishnan, M., Cihlar, T., Tseng, C. T. K., Makino, S., Menachery, V. D., Bilello, J. P. & Shi, P. Y., Dec 2021, In: Nature communications. 12, 1, 3984.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Bepridil is potent against SARS-CoV-2 in vitro
Vatansever, E. C., Yang, K. S., Drelich, A. K., Kratch, K. C., Cho, C. C., Kempaiah, K. R., Hsu, J. C., Mellott, D. M., Xu, S., Tseng, C. T. K. & Liu, W. R., Mar 9 2021, In: Proceedings of the National Academy of Sciences of the United States of America. 118, 10, e2012201118.Research output: Contribution to journal › Article › peer-review
Open Access21 Scopus citations
Press / Media
-
GNL animal studies support COVID-19 effectiveness of Adamis antioxidant drug
3/17/21
1 item of Media coverage
Press/Media: Expert Comment
-
-Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model
3/16/21
2 items of Media coverage
Press/Media: Expert Comment
-
Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model
3/15/21
18 items of Media coverage
Press/Media: Expert Comment
-
COVID-19: Angina drug may be an effective treatment
2/26/21
1 item of Media coverage
Press/Media: Expert Comment
-
Rapid method finds potent COVID-19 monoclonal antibody among a trillion possibilities
11/2/20 → 11/5/20
7 items of Media coverage
Press/Media: Expert Comment